首页 > 市场调查报告书 > 製药

癌症

市场调查报告书

商品编码

1356767

大肠直肠癌市场报告：2030 年趋势、预测与竞争分析

Colorectal Cancer Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: 2023年09月01日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

大肠直肠癌趋势和预测

预计到 2030 年，全球大肠癌市场将达到 219 亿美元，2024 年至 2030 年年复合成长率为 4.1%。这个市场的主要促进因素是老年人口的增加、不健康的饮食习惯和异食癖时间的增加以及人们对结直肠癌的认识不断增强。全球大肠直肠癌市场前景未来性，有手术/放射线治疗、化疗、标靶治疗、抗药性治疗等市场机会。

大肠直肠癌市场洞察

Lucintel 预测，由于人们越来越关注各种具有准确诊断测试的治疗程序，直肠指检将在预测期内实现最高增长。

化疗是大肠直肠癌最常见的治疗方法，因为它通常涉及静脉或口服给药抗癌药物，这些药物透过血流直接输送到体内。

由于消费者对大肠直肠癌诊断和治疗的认识不断提高，以及政府对该地区结直肠癌治疗和药物开发的支持力度加大，预计北美地区在预测期内将经历最高的增长。

本报告回答了 11 个关键问题：

Q.1. 细分市场中最有前途和高成长的机会是什么？
Q.2.哪个细分市场将以更快的速度成长？为什么？
Q.3.您认为哪些地区未来会出现更快的成长？为什么？
Q.4. 影响市场动态的主要要素有哪些？市场的主要挑战和商业风险是什么？
Q.5. 这个市场的商业风险和竞争威胁是什么？
Q.6.这个市场有哪些新趋势？为什么？
Q.7.市场客户需求有何改变？
Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
Q.10. 该市场上的竞争产品有哪些，由于材料或产品替代导致市场占有率下降的威胁有多大？
Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

宏观经济趋势（2018-2023）与预测（2024-2030）
全球大肠直肠癌市场趋势（2018-2023）与预测（2024-2030）
全球大肠直肠癌诊断市场
- 手指直肠检查
- 大便潜血试验
- 软式乙状结肠镜检查
- 内视镜
- 虚拟内视镜
全球大肠直肠癌治疗市场
- 手术/放射线治疗
- 化疗
- 标靶治疗
- 对药物治疗产生抗药性
- 其他的

第4章2018-2030年分地区市场趋势及预测分析

按地区分類的全球大肠直肠癌市场
北美大肠癌市场
欧洲大肠直肠癌市场
亚太大肠直肠癌市场
其他地区大肠直肠癌市场

第5章竞争分析

产品系列分析
营运整合
波特五力分析

第6章成长机会与策略分析

成长机会分析
- 全球大肠直肠癌市场诊断成长机会
- 全球大肠直肠癌治疗市场成长机会
- 按地区分類的全球大肠直肠癌市场成长机会
全球大肠直肠癌市场新趋势
战略分析
- 新产品开发
- 扩大全球大肠直肠癌市场的产能
- 全球大肠直肠癌市场的合併、收购与合资企业
- 认证和许可

第7章主要企业概况

Abbott Diagnostics
Alere
Beckman Coulter
Clinical Genomics
Companion Dx
Hoffmann La Roche
Debiopharm
Vaccinogen BD

简介目录

Colorectal Cancer Trends and Forecast

The future of the global colorectal cancer market looks promising with opportunities in the urgery & radiation therapy, chemotherapy, targeted therapies, and resistance to pharmacological therapies markets. The global colorectal cancer market is expected to reach an estimated $21.9 billion by 2030 with a CAGR of 4.1% from 2024 to 2030. The major drivers for this market are growing geriatric population, increasing unhealthy food habits and odd food consumption timing of individual, and rising awareness towards colorectal cancer.

A more than 150-page report is developed to help in your business decisions.

Colorectal Cancer by Segment

The study includes a forecast for the global colorectal cancer by diagnosis, treatment, and region.

Colorectal Cancer Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:

Digital Rectal Examination
Fecal Occult Blood Test
Flexible Sigmoidoscopy
Colonoscopy
Virtual Colonoscopy

Colorectal Cancer Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

Surgery and Radiation Therapy
Chemotherapy
Targeted Therapies
Resistance to Pharmacological Therapies
Others

Colorectal Cancer Market by Region [Shipment Analysis by Value from 2018 to 2030]:

North America
Europe
Asia Pacific
The Rest of the World

List of Colorectal Cancer Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies colorectal cancer companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the colorectal cancer companies profiled in this report include-

Abbott Diagnostics
Alere
Beckman Coulter
Clinical Genomics
Companion Dx
Hoffmann La Roche
Debiopharm
Vaccinogen BD

Colorectal Cancer Market Insights

Lucintel forecasts that digital rectal examination is expected to witness highest growth over the forecast period due to growing prominence for the various treatment procedures by performing accurate diagnostic tests.

Within this market, chemotherapy will remain the largest segment as it is generally a treatment with injectable cancer drugs into a vein or orally by mouth, which helps them directly reach body parts through the bloodstream travel and is the most commonly used method to treat colorectal cancer.

North America is expected to witness highest growth over the forecast period due to the increasing awareness among consumers about the diagnosis and treatment of colorectal cancer and growing government support to develop colorectal cancer procedures and drugs in this region.

Features of the Global Colorectal Cancer Market

Market Size Estimates: Colorectal cancer market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Colorectal cancer market size by diagnosis, treatment, and region. in terms of value ($B).

Regional Analysis: Colorectal cancer market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diagnosis, treatment, and region.s for the colorectal cancer market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the colorectal cancer market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the colorectal cancer market size?

Answer: The global colorectal cancer market is expected to reach an estimated $21.9 billion by 2030.

Q.2. What is the growth forecast for colorectal cancer market?

Answer: The global colorectal cancer market is expected to grow with a CAGR of 4.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the colorectal cancer market?

Answer: The major drivers for this market are growing geriatric population, increasing unhealthy food habits and odd food consumption timing of individual, and rising awareness towards colorectal cancer.

Q.4. What are the major segments for colorectal cancer market?

Answer: The future of the colorectal cancer market looks promising with opportunities in the urgery & radiation therapy, chemotherapy, targeted therapies, and resistance to pharmacological therapies markets.

Q.5. Who are the key colorectal cancer market companies?

Answer: Some of the key colorectal cancer companies are as follows:

Abbott Diagnostics
Alere
Beckman Coulter
Clinical Genomics
Companion Dx
Hoffmann La Roche
Debiopharm
Vaccinogen BD

Q.6. Which colorectal cancer market segment will be the largest in future?

Answer: Lucintel forecasts that digital rectal examination is expected to witness highest growth over the forecast period due to growing prominence for the various treatment procedures by performing accurate diagnostic tests.

Q.7. In colorectal cancer market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the increasing awareness among consumers about the diagnosis and treatment of colorectal cancer and growing government support to develop colorectal cancer procedures and drugs in this region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the colorectal cancer market by diagnosis (digital rectal examination, fecal occult blood test, flexible sigmoidoscopy, colonoscopy, and virtual colonoscopy), treatment (surgery & radiation therapy, chemotherapy, targeted therapies, resistance to pharmacological therapies, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Global Colorectal Cancer Market : Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Colorectal Cancer Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Colorectal Cancer Market by Diagnosis
- 3.3.1: Digital Rectal Examination
- 3.3.2: Fecal Occult Blood Test
- 3.3.3: Flexible Sigmoidoscopy
- 3.3.4: Colonoscopy
- 3.3.5: Virtual Colonoscopy
3.4: Global Colorectal Cancer Market by Treatment
- 3.4.1: Surgery and Radiation Therapy
- 3.4.2: Chemotherapy
- 3.4.3: Targeted Therapies
- 3.4.4: Resistance to Pharmacological Therapies
- 3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

4.1: Global Colorectal Cancer Market by Region
4.2: North American Colorectal Cancer Market
- 4.2.2: North American Colorectal Cancer Market by Treatment: Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies, and Others
4.3: European Colorectal Cancer Market
- 4.3.1: European Colorectal Cancer Market by Diagnosis: Digital Rectal Examination, Fecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, and Virtual Colonoscopy
- 4.3.2: European Colorectal Cancer Market by Treatment: Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies, and Others
4.4: APAC Colorectal Cancer Market
- 4.4.1: APAC Colorectal Cancer Market by Diagnosis: Digital Rectal Examination, Fecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, and Virtual Colonoscopy
- 4.4.2: APAC Colorectal Cancer Market by Treatment: Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies, and Others
4.5: ROW Colorectal Cancer Market
- 4.5.1: ROW Colorectal Cancer Market by Diagnosis: Digital Rectal Examination, Fecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, and Virtual Colonoscopy
- 4.5.2: ROW Colorectal Cancer Market by Treatment: Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies, and Others

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Colorectal Cancer Market by Diagnosis
- 6.1.2: Growth Opportunities for the Global Colorectal Cancer Market by Treatment
- 6.1.3: Growth Opportunities for the Global Colorectal Cancer Market by Region
6.2: Emerging Trends in the Global Colorectal Cancer Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Colorectal Cancer Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Colorectal Cancer Market
- 6.3.4: Certification and Licensing